Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-18-002935
Filing Date
2018-03-22
Accepted
2018-03-22 16:03:25
Documents
1
Period of Report
2018-02-21

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 14031
  Complete submission text file 0001654954-18-002935.txt   15429
Mailing Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07922
Business Address 1430 HIGHWAY 206 SUITE 200 BEDMINSTER NJ 07922 908-517-9500
CorMedix Inc. (Issuer) CIK: 0001410098 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KLEINBERG, KAPLAN, WOLFF & COHEN, PC 551 FIFTH AVENUE, 18TH FLOOR NEW YORK NY 10176
Business Address
Kaplan Myron (Reporting) CIK: 0001672645 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34673 | Film No.: 18706958